Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Optimi Health Corp. - SIC # 2830 -
Ticker
Exchange
SIC #
Website
Latest Ticker
OPTH
Nasdaq
2830
www.optimihealth.ca
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Optimi Health Corp.
Optimi Health Establishes Optimi Australia Pty Ltd as Dedicated Distribution and Business Development Entity
- Oct 26th, 2026 6:00 am
Optimi Health Completes MDMA Production for Phase 3 PTSD Trial in Canada, MAPS Trial in Israel and Commercial Supply in Australia
- Oct 20th, 2026 6:30 am
Optimi Health to Present at the ThinkEquity Conference
- Oct 7th, 2026 7:00 am
Optimi Health Appoints Melanie Pump to Board of Directors
- Sep 29th, 2026 5:30 am
Optimi Health Completes Psilocybin Production for Phase 2 MDD Trial
- Sep 23rd, 2026 9:58 am
Optimi Health Completes Psilocybin Production for Health Canada-Approved Phase 2 MDD Trial and Commercial TRD Supply
- Sep 23rd, 2026 7:00 am
Optimi Health Appoints Dr. Michael Blough as Chief Clinical Development Officer
- Sep 22nd, 2026 7:00 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector
- Sep 21st, 2026 9:01 am
Elon Musk Once Said Psychedelics Could Help PTSD — Now FDA Holds Hearing as Optimi Health Advances MDMA Trial
- Sep 18th, 2026 6:30 pm
These Biotech Stocks Are Cheap Based On 1 Fundamental Measure
- Sep 17th, 2026 3:34 pm
Optimi Health Expands Clinical Program with Phase 3 Trial Evaluating MDMA-Assisted Therapy for Post-Traumatic Stress Disorder
- Sep 16th, 2026 6:25 am
3 Small Cap Stocks With Strong Revenue Growth And Low Debt
- Sep 15th, 2026 6:46 pm
Optimi Health to Initiate Phase 2 Clinical Trial Evaluating Psilocybin-Assisted Therapy for Major Depressive Disorder
- Sep 10th, 2026 6:45 am
Optimi Health to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
- Sep 8th, 2026 6:30 am
3 Revenue Generating Psychedelics Stocks Retail Investors Are Screening Right Now
- Aug 20th, 2026 11:16 pm
Optimi Health Establishes $100 Million Equity Facility as Psychedelic Commercialisation Advances
- Aug 19th, 2026 12:03 am
Scroll